English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Genzyme Corporation
Carol Ostrow
| Sep 23, 2017
Study shows Dupixent reduces symptoms of atopic dermatitis
Carol Ostrow
| Sep 20, 2017
Sanofi partner Alnylam to suspend fitusiran trial for treating hemophilia
Nicholas Gueguen
| Aug 4, 2017
Sanofi Genzyme observes Rare Disease Day globally
Ruth de Jauregui
| May 7, 2017
Data from multiple sclerosis medication study shows promise
Ruth de Jauregui
| May 7, 2017
Sanfoli Genzyme releases 6 years of data on Lemtrada in patients with relapsing remitting multiple sclerosis
Ruth de Jauregui
| May 7, 2017
Survey finds majority of rheumatoid arthritis patients living in pain
Ruth de Jauregui
| Mar 29, 2017
Multiple Myeloma Journey Partners Program to expand
Robert Lawson
| Feb 19, 2017
Trial focuses on common genetic link to Parkinson's
Trending
+
Pharmaceuticals
Patient Daily
| Sep 23, 2025
Wall Street Journal editorial board alleges hospitals misuse 340B program
+
Pharmaceuticals
Patient Daily
| Sep 22, 2025
Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
Patient Daily
| Sep 19, 2025
ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’
+
Pharmaceuticals
Patient Daily
| Sep 22, 2025
Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'
